Clinical trial NCT03473470: Evaluation of the Active Warming Effects on Maternal and Neonatal Outcome During Cesarean Delivery
Official title: Evaluation of the Active Warming Effects on Maternal and Neonatal Outcomes During Cesarean Delivery
Study type: INTERVENTIONAL
Overall status: UNKNOWN
Phase: NA
Conditions: Hypothermia; Anesthesia
Keywords: Maternal and Neonatal Hypothermia, cesarean delivery
Lead sponsor: University of Foggia
Sponsor class: OTHER
First posted: 2018-03-22
Enrollment: 165
Sex: FEMALE
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: yes
Allocation: RANDOMIZED
Intervention model: CROSSOVER
Primary purpose: OTHER

Brief summary: A prospective randomized study of healthy term parturients undergoing cesarean delivery was designed to assess the impact of the active warming on perioperative and postoperative temperature.

The main objective is to evaluate the maternal core temperature in the perioperative and postoperative period during cesarean delivery.

The secondary objectives are to assess the incidence of maternal hypothermia, the incidence of maternal shivers, the evaluation of maternal thermal comfort, the neonatal temperature at birth, the Apgar score at 1 and 5 minutes, the umbilical pH, the evaluation of coagulative assessment in case of maternal hypothermia trough the use of thromboelastography.

The patients are randomized into three groups: a group of no warmed patients, a second group of Active waming patients with iv fluids and lower body forced air warming and a third group of Active warming patients with only warmed iv fluids.

The inclusion criteria are healthy parturients up to age 18. The exclusion criteria included parturients who develop fever, diabetes mellitus, BMI up to 40kg/ m2, coagulative disorders, pre eclampsia or eclampsia, all the factors that can cause intraoperative bleeding such as placental abruption or antecedent placenta overgrowth ( placenta previa).

Detailed description: The doctor's main purposes during the perioperative period are the monitorign and maintenance of normothermia, as well as the haemodynamic, respiratory, metabolic, analgesic control and monitoring.

Mild hypothermia ( core temperature between 36° and 33° C) is common during general, locoregional or blended anaesthesia. A mild hypothermia can cause a cardiovascular, haematological, metaolic and hormonal alterations that can explain an increased mortality and morbidity in hypothermia patients versus normothermia patients.

Thermic decrease is a physiological event during general or locoregional anaesthesia. Particularly spinal and epidural anaesthesia can cause the thermic decrease because of vasodilation below the level of the sensitive and neuroaxial blockade. In this way there is in the patient an increased heat loss trough radiation. The neuroaxial techniques can reduce the sensory connections and the level of vasoconstriction above the level of the sensorial blockade, reducing the patient capacity to maintain the poichilothermia.

The consequences of hypothermia are important because they can influence the intraoperative management causing complications extending the recovering time and the hospitalization.

The environmental temperature is a critical factor for the development of hypothermia , especially in critically patients. In order to avoid the deveopment of hypothermia the environmental temperature must be maintainde between 21° and 24° C and humidity level of 40- 60%.

Maternal hypothermia is common during cesarean delivery and it can exercise influence over neonatal temperature.

When a mother develops hypothermia the newborn can shows hypotheria, umbilical acidosis, low Apgar score at birth.

The recorded data are the demographic data of the patient such as weight, age and height, the vital signs such as heart rate, arterial pressure, SpO2 or EtCO2 during general anaesthesia, BMI, gestational age and parity, type of anaesthesia, doses and type of anaesthetic used, the development of adverse effects such as hypothermia or hypothension, the blood leaks, the environmental temperature on operative theatre, the temperature of fluids iv in the perioperative period, the maternal core temperature at preoperative, during induction of anaesthesia, after 5 minutes initiating anaesthesia, and then every 10 minutes until the end of the cesarean delivery and also at child birth, at the exit of operative theatre. Maternal temperature measurment will be obtained by using a skin sensor Spot On on a temporal region, the neonatal axillary temperature at 1 and5 minutes from birth using a digital thermometer, Apgar score and umbilical cord blood pH, the pain evaluation using a VAS scale ( 0-10), the maternal shivering by the Bedside Shivering Assessment scale, the maternal comfort using a verbal numerical scale ( 0 = as worst immaginable cold 50= as thermoneutral and 100= as insufferably hot), the timing of pain at induction of anaesthesia and then every 10 minutes until the operative room exit.

Eligibility criteria: Inclusion Criteria: all healthy parturients over eighteen years undergoing cesarean delivery

Exclusion Criteria:

* Fever;
* Diabetes mellitus;
* BMI\> 40Kg/m²;
* Coaugulation disorders;
* Pre-eclampsia and eclampsia;
* Increased risk of intraoperative hemorrhage

Primary outcomes:
measure: incidence of hypothermia (body temperature < 36°C)
timeFrame: From the date of randomization until the end of surgery, up to four hours of surgery
Secondary outcomes:
measure: Incidence of maternal shivering
timeFrame: From the date of randomization until the end of surgery, up to four hours of surgery
measure: Neonatal body temperature (T°C)
timeFrame: From neonatal birth until five minutes after the birth
measure: Neonatal Apgar score
timeFrame: From neonatal birth and until five minutes after the birth
measure: Incidence of maternal coagulative disorders
timeFrame: From the date of randomization until the end of surgery, up to four hours of surgery
measure: maternal thermal comfort
timeFrame: From the date of randomization until the end of surgery, up to four hours of surgery
Other outcomes:
Locations:
city: Foggia
country: Italy
facility: Ospedali Riuniti
state: Puglia
Study officials:
affiliation: University of Foggia
name: Antonella Cotoia, MD
role: PRINCIPAL_INVESTIGATOR
References: